Carl Ross is the director of Waisman Biomanufacturing, which is affiliated with the university. He says the drug, GIGA-2050, is different from a vaccine because it won’t provide long-term immunity.
University Communications
Carl Ross is the director of Waisman Biomanufacturing, which is affiliated with the university. He says the drug, GIGA-2050, is different from a vaccine because it won’t provide long-term immunity.